Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasopressin during laparoscopic cystectomy for ovarian endometrioma
IRCT20200925048836N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Sep 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, open-label trial of vasopressin in endometrioma and endometriosis (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Change in anti-Mullerian hormone, Number of cauterization points for hemostasis and 1 more. Started Sep 2019; status: completed.
02
Drugs
vasopressin
03
Conditions
endometriomaendometriosis
Beyond the preview
Go deeper on IRCT20200925048836N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200925048836N1.